Aparajit Ballave Dey

Dr. Aparajit Ballave Dey

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2012 in The Journal of nutrition, health and aging
Verified
Journal Article
Open access
PDF file
DKD. Khandelwal
D. Khandelwal
AGA. Goel
A. Goel
UKU. Kumar
U. Kumar
VGV. Gulati
V. Gulati
RNR. Narang
R. Narang
ADAparajit Ballave Dey
Aparajit Ballave Dey
With the onset of frailty, there is often a rapid, progressive, and self-perpetuating downward spiral towards death. Frailty has enormous impact on acute hospital care and has been shown to be a more effective predictor of mortality than conventional clinical measures.

19 May 2021 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
SSSunny Singhal
Sunny Singhal
PKPramod Kumar
Pramod Kumar
SSSumitabh Singh
Sumitabh Singh
SSSrishti Saha
Srishti Saha
ADAparajit Ballave Dey
Aparajit Ballave Dey
Background: Few studies have focused on exploring the clinical characteristics and outcomes of COVID-19 in older patients. We conducted this systematic review and meta-analysis to have a better understanding of the clinical characteristics of older COVID-19 patients. Methods: A systematic search of PubMed and Scopus was performed from December 2019 to May 3rd, 2020. Observational studies including older adults (age ≥ 60 years) with COVID-19 infection and reporting clinical characteristics or outcome were included. Primary outcome was assessing weighted pooled prevalence (WPP) of severity and outcomes. Secondary outcomes were clinical features including comorbidities and need of respiratory support. Result: Forty-six studies with 13,624 older patients were included. Severe infection was seen in 51% (95% CI– 36-65%, I2–95%) patients while 22% (95% CI– 16-28%, I2–88%) were critically ill. Overall, 11% (95% CI– 5-21%, I2–98%) patients died. The common comorbidities were hypertension (48, 95% CI– 36-60% I2–92%), diabetes mellitus (22, 95% CI– 13-32%, I2–86%) and cardiovascular disease (19, 95% CI – 11-28%, I2–85%). Common symptoms were fever (83, 95% CI– 66-97%, I2–91%), cough (60, 95% CI– 50-70%, I2–71%) and dyspnoea (42, 95% CI– 19-67%, I2–94%). Overall, 84% (95% CI– 60-100%, I2–81%) required oxygen support and 21% (95% CI– 0-49%, I2–91%) required mechanical ventilation. Majority of studies had medium to high risk of bias and overall quality of evidence was low for all outcomes. Conclusion: Approximately half of older patients with COVID-19 have severe infection, one in five are critically ill and one in ten die. More high-quality evidence is needed to study outcomes in this vulnerable patient population and factors affecting these outcomes.

7 August 2014 in Aging Cell
Verified
Journal Article
Open access
PDF file
RKRahul Kumar
Rahul Kumar
NMNavinath Mohan
Navinath Mohan
AUAshish Datt Upadhyay
Ashish Datt Upadhyay
ASAmrendra Pratap Singh
Amrendra Pratap Singh
VSVishal Sahu
Vishal Sahu
SDSharmistha Dey
Sharmistha Dey
Summary: Frailty has emerged as a major health issue among older patients. A consensus on definition and diagnosis is yet to be achieved. Various biochemical abnormalities have been reported in frailty. Activation of sirtuins, a conserved family of NAD‐dependent proteins, is one of the many mimics of calorie restriction which improves lifespan and health in experimental animals. In this cross‐sectional study, we assessed the circulating sirtuin levels in 119 (59.5%) nonfrail and 81 (40.5%) frail individuals, diagnosed by Fried's criteria. Serum SIRT1, SIRT2, and SIRT3 were estimated by surface plasmon resonance (SPR) and Western blot. Serum sirtuins level in mean+SD; SIRT1 (nonfrail –4.67 ± 0.48 ng/μL; frail – 3.72 ± 0.48 ng/μL; P < 0.0001), SIRT2 (nonfrail – 15.18 ± 2.94 ng/μL; frail – 14.19 ± 2.66 ng/μL; P = 0.016), and SIRT3 (nonfrail‐7.72 ± 1.84 ng/μL; frail – 6.12 ± 0.97 ng/μL; P < 0.0001) levels were significantly lower among frail patients compared with the nonfrail. In multivariable regression analysis, lower sirtuins level were significantly associated with frailty after adjusting age, gender, diabetes mellitus, hypertension, cognitive status (Mini Mental State Examination scores) and number of comorbidities. For detecting the optimum diagnostic cutoff value a ROC analysis was carried out. The area under curve for SIRT1 was 0.9037 (cutoff – 4.29 ng/μL; sensitivity – 81.48%; specificity – 79.83%) and SIRT3 was 0.7988 (cutoff – 6.61 ng/μL; sensitivity – 70.37%; specificity – 70.59%). This study shows that lower circulating SIRT1 and SIRT3 levels can be distinctive marker of frailty.

31 July 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
JLJinkook Lee
Jinkook Lee
JBJoyita Banerjee
Joyita Banerjee
PKPranali Yogiraj Khobragade
Pranali Yogiraj Khobragade
MAMarco Angrisani
Marco Angrisani
ADAparajit Ballave Dey
Aparajit Ballave Dey
Introduction Alzheimer’s disease and related dementias can be considered the epidemic of the 21st century. Particularly, the predicted growth in the size of elderly populations in low-income and middle-income countries is expected to produce a dramatic surge in dementia prevalence and incidence. Although a rising burden of dementia presents an urgent challenge for India, previous efforts to study dementia in the country have relied on non-representative samples in geographically restricted regions. The Harmonised Diagnostic Assessment of Dementia for the Longitudinal Aging Study in India (LASI-DAD) will provide rich, population-representative data on late-life cognition and dementia and their risk factors for the first time in India. Methods The LASI-DAD will recruit a sample of 3000 people aged 60+ years. Their family members or friends, whom respondents nominate as informants, participate in the computer-assisted personal interview. The study sample is drawn from the ongoing, nationally representative Longitudinal Aging Study in India, a multipurpose panel survey of aging. We aim to collect rich data on cognitive and neuropsychological tests, informant reports, and epidemiological data through a comprehensive geriatric assessment, and venous blood collection and assays. For a subsample, we collect neuroimaging data. Data collection is currently in progress in 14 States and Union Territories of India. Clinicians will provide clinical consensus diagnosis based on the Clinical Dementia Rating. Ethics and dissemination Ethics approval was obtained from the Indian Council of Medical Research and all collaborating institutions. Anonymised data will be available for the larger research community through a secured website hosted by the Gateway to Global Aging Data platform. Research findings from the LASI-DAD team will be disseminated through journal publications and presentations at professional conferences.

1 August 2020 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
JLJinkook Lee
Jinkook Lee
PKPranali Y. Khobragade
Pranali Y. Khobragade
JBJoyita Banerjee
Joyita Banerjee
SCSandy Chien
Sandy Chien
MAMarco Angrisani
Marco Angrisani
ADAparajit Ballave Dey
Aparajit Ballave Dey

1 January 2017 in Indian Journal of Medical Research
Verified
Journal Article
Open access
PDF file
ADAparajit Ballave Dey
Aparajit Ballave Dey
Indian J Med Res, Official publication of Indian Council of Medical Research,India